Figure 3
From: A pilot open-label trial of minocycline in patients with autism and regressive features
![Figure 3](http://media.springernature.com/full/springer-static/image/art%3A10.1186%2F1866-1955-5-9/MediaObjects/11689_2012_Article_38_Fig3_HTML.jpg)
The levels of hepatic growth factor (HGF) in cerebrospinal fluid (CSF) were significantly increased following treatment with minocycline. (P = 0.028).